Phospho-Caspase-8 (S347) Polyclonal Antibody

CASP8 (caspase 8) encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined.

Introducing the Phospho-Caspase-8 (S347) Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to facilitate advanced research in the field of cell biology. This antibody, derived from a polyclonal source, exhibits exceptional specificity and sensitivity, enabling precise detection and analysis of the phosphorylated form of Caspase-8 at serine 347.

Crafted with utmost precision and utilizing state-of-the-art technology, this antibody offers researchers an invaluable resource for investigating the intricate mechanisms underlying apoptotic pathways. By targeting the phosphorylated form of Caspase-8, this antibody enables the elucidation of critical signaling events involved in cellular apoptosis, paving the way for a deeper understanding of various physiological and pathological processes.

The Phospho-Caspase-8 (S347) Polyclonal Antibody boasts an exceptional affinity for its target, ensuring reliable and reproducible results. Its high specificity guarantees minimal cross-reactivity, thereby minimizing the risk of false-positive or false-negative outcomes. This antibody's superior sensitivity empowers researchers to detect even low levels of phosphorylated Caspase-8, facilitating the exploration of subtle cellular responses and signaling cascades.

Furthermore, this antibody has been rigorously validated through a series of stringent quality control measures, ensuring its reliability and consistency. Its performance has been thoroughly assessed in various experimental settings, including Western blotting, immunohistochemistry, and immunofluorescence, thereby attesting to its versatility and adaptability across diverse research applications.

In summary, the Phospho-Caspase-8 (S347) Polyclonal Antibody represents a breakthrough in the realm of cell biology research. Its exceptional specificity, sensitivity, and reliability make it an indispensable tool for scientists seeking to unravel the intricate mechanisms governing apoptotic pathways. With this antibody, researchers can confidently delve into the complexities of cellular apoptosis, shedding light on fundamental biological processes and potentially uncovering novel therapeutic targets.